Sun Pharmaceutical Industries Ltd

Mumbai, India

An Indian multinational pharmaceutical company headquartered in Mumbai, known for manufacturing and marketing pharmaceutical products.

CCI Score

-2.38

-7.52% June 14

Latest Event

Sun Pharma Halol Plant Receives 8 USFDA Observations

Sun Pharmaceutical Industries Ltd received 8 observations on its Halol manufacturing facility from the USFDA following a GMP inspection conducted between June 2 and 13, 2025. The company has vowed to undertake remedial steps and submit a comprehensive remediation plan in response to the Form 483 issued.

Take Action

So what can you do? It's time to make tough choices. Where will you cast your vote?

Shop Alternatives SEE ALL: BMS

Hikma

GSK
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

BYSTANDER

Sun Pharmaceutical Industries Ltd is currently rated as a Bystander.

-1 to -4 CCI Score

Companies scoring here do little to oppose authoritarianism. Their inaction results in a passive endorsement of the status quo, as they neither actively resist oppression nor contribute to overt support for it.

Latest Events

JUN

13

2025

Sun Pharma Halol Plant Receives 8 USFDA Observations
-40.00

Sun Pharmaceutical Industries Ltd received 8 observations on its Halol manufacturing facility from the USFDA following a GMP inspection conducted between June 2 and 13, 2025. The company has vowed to undertake remedial steps and submit a comprehensive remediation plan in response to the Form 483 issued.
FEB

06

2025

Sun Pharma 2024 Political Contributions and Lobbying
-4.83

Sun Pharmaceutical Industries Ltd disclosed political contributions totaling $182,941 and lobbying expenses of $240,000 for the 2024 cycle, based on campaign finance data released by the FEC and Senate Office of Public Records. This event highlights the company's involvement in political financing in the US.
-5

Political Contributions and Lobbying Efforts

June 14

The reported political contributions and lobbying efforts, while modest in figures, indicate Sun Pharma's engagement in facilitating political influence. From an anti-authoritarian perspective, such financial involvement, even if not as extensive as other major companies, can contribute to corporate influence over policy and is therefore scored negatively.

Sun Pharmaceutical Industries Profile: Summary
AUG

01

2024

Sun Pharma Updates Human Rights Policy
73.34

Sun Pharma has released a revised Human Rights Policy outlining measures to protect human rights, ensure fair labor practices, and promote non-discrimination across its operations and value chain.
+80

Labor Relations and Human Rights Practices

June 14

The updated Human Rights Policy underscores Sun Pharma's commitment to protecting workers' rights, prohibiting child and forced labor, and promoting inclusion and non-discrimination. This stance directly supports ethical labor practices and opposes authoritarian exploitation, reflecting a strong anti-fascist posture.

Human Rights Policy
JAN

01

2023

Sun Pharma Electoral Bond Donation to BJP
-54.77

Sun Pharma Laboratories Limited donated electoral bonds amounting to Rs. 31,50,00,000.00 to the Bharatiya Janata Party, as reported by MyNeta. The donation, made through electoral bond mechanism, ties the company to support for a right-wing political party known for its nationalist policies.
-70

Political Contributions and Lobbying Efforts

June 14

The donation of electoral bonds by Sun Pharma Laboratories Limited to the BJP—an organization associated with far-right nationalist policies—indicates corporate support for political entities with authoritarian leanings. Such political contributions are viewed negatively from an anti-fascist perspective.

Electoral Bond - SUN PHARMA LABORATORIES LIMTED
JAN

01

2023

Optimized Supply Chain and Local Sourcing
44.34

Sun Pharma's Sustainability Report highlights a robust supply chain management system emphasizing efficiency, regular ESG audits, and local sourcing. These actions not only aim to streamline operations but also support local businesses and reduce environmental impact, reinforcing ethical business practices.
+70

Supply Chain Ethics

June 14

Sun Pharma’s detailed supply chain strategy incorporates regular ESG audits, supplier reviews, and stringent monitoring to ensure compliance with ethical and labor standards. This proactive approach in supply chain ethics supports transparency, accountability, and benefits local communities by emphasizing local sourcing.

Focusing on Supply Chain Efficiency
+40

Economic Collaboration

June 14

The report underscores local sourcing as a pivotal strategy to minimize import dependence and currency risk while fostering economic growth and job creation in local communities. This emphasis on economic collaboration is a positive step toward supporting local industry and reducing reliance on global supply chains.

Focusing on Supply Chain Efficiency
APR

15

2019

Sun Pharma's Electoral Bond Donation
-32.37

Sun Pharma Laboratories Limited, a subsidiary of Sun Pharmaceutical Industries, donated Rs 31.5 crore via electoral bonds to political parties during the financial year 2019-20. The opaque nature of electoral bonds raises concerns about corporate influence in politics and transparency, potentially facilitating authoritarian political practices.
-60

Political Contributions and Lobbying Efforts

June 14

The donation of Rs 31.5 crore via electoral bonds, a mechanism known for its lack of transparency, indicates an effort to exert corporate influence over political processes without public accountability. Such actions are concerning from an anti-fascist perspective as they could enable authoritarian political funding.

Environmental violations troubled Sun Pharma group donated Rs 31.5 crore to political parties